Cobblestone Capital Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Cobblestone Capital Advisors's DGX Position: Q4 2021 in Review
Cobblestone Capital Advisors sold out of Quest Diagnostics (DGX) in Q4 2021, closing a stake of 2,325 shares — an estimated $338K sold.
Cobblestone Capital Advisors first reported a position in DGX in Q2 2013 and held it in 29 quarters. The position peaked at $338K in Q3 2021. 904 funds tracked by Wall St. Rank hold DGX as of Q4 2021.
- Cobblestone Capital Advisors reported no remaining Quest Diagnostics position as of Q4 2021 after selling out during the quarter.
- Cobblestone Capital Advisors sold 2,325 Quest Diagnostics shares in Q4 2021, an estimated $338K.
- Cobblestone Capital Advisors first reported a position in Quest Diagnostics in Q2 2013 and held it in 29 quarters.
- Cobblestone Capital Advisors's Quest Diagnostics position peaked at $338K in Q3 2021.
- 904 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.
Based on Cobblestone Capital Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.